Jul. 10, 2020—Dr. David Aronoff, Addison B. Scoville Jr. Chair in Medicine and professor of pathology, microbiology and immunology, discusses why it's important for everyone on the Vanderbilt campus to continue COVID-19 safety measures.
May. 28, 2020—A new paper proposes an ethical way to test drug safety during pregnancy by using electronic health data to conduct "virtual" drug trials.
Apr. 15, 2020—In her latest video message, Interim Chancellor and Provost Susan R. Wente discusses COVID-19 with Dr. David Aronoff, professor of medicine, pathology, microbiology and immunology and director of the Division of Infectious Diseases at Vanderbilt University Medical Center.
Apr. 3, 2020—Vanderbilt University faculty are sharing their expertise on a range of topics related to COVID-19.
Sep. 24, 2019—An inexpensive generic drug once used to prevent gastrointestinal ulcers in people taking daily NSAIDs protects against C. diff infection in mice.
Jan. 17, 2019—David Aronoff and colleagues report an increased risk of the serious gastrointestinal infection C. diff following the use of NSAID pain relievers.
Apr. 19, 2018—Drug repurposing involves establishing an additional approved indication for a drug already at market.
Mar. 22, 2018—According to the Centers for Disease Control and Prevention, in 2011 in the United States there were almost half a million Clostridium difficile infections, and one in 11 patients 65 or older with a healthcare-associated C. diff infection died within 30 days of diagnosis.
Apr. 27, 2017—Infectious diseases specialist David Aronoff, M.D., recently became one of 73 new fellows of the American Academy of Microbiology, an honorific leadership group within the American Society of Microbiology.
Sep. 28, 2016—Nine faculty members who hold endowed chairs were honored and donors were thanked during a festive celebration Sept. 26 at the Student Life Center.
Nov. 14, 2013—David Aronoff, M.D., has been named the new director of Vanderbilt University Medical Center’s Division of Infectious Diseases.